Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC2 | O75106 | 3/20 | 0.38 |
| ▸ | CPT2 | P23786 | 1/20 | 0.37 |
| ▸ | CPT1A | P50416 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | TRAP1 | Q12931 | 2/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MTHFD1 | P11586 | 1/20 | 0.34 |
| ▸ | MTHFD2 | P13995 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL21768123 | 1.00 | AOC2 (0.38) | AOC2CPT2CPT1ANPC1TRAP1 | |
| Trifluoroacetic Acid SCHEMBL30089532 | 1.00 | AOC2 (0.38) | AOC2CPT2CPT1ANPC1TRAP1 | |
| Trifluoroacetic Acid SCHEMBL21768048 | 1.00 | AOC2 (0.38) | AOC2CPT2CPT1ANPC1TRAP1 | |
| Trifluoroacetic Acid SCHEMBL30089527 | 1.00 | AOC2 (0.38) | AOC2CPT2CPT1ANPC1TRAP1 | |
| SCHEMBL21780058 | 0.95 | AOC2 (0.41) | AOC2CPT2CPT1ANPC1TRAP1 | |
| SCHEMBL21780057 | 0.95 | AOC2 (0.41) | AOC2CPT2CPT1ANPC1TRAP1 | |
| Trifluoroacetic Acid SCHEMBL30089447 | 0.89 | HPGD (0.45) | NPC1AOC3ALDH1A1HPGDSMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL30089479 | 0.89 | HPGD (0.45) | NPC1AOC3ALDH1A1HPGDSMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL30089487 | 0.89 | HPGD (0.45) | NPC1AOC3ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL21780098 | 0.83 | HPGD (0.50) | NPC1AOC3ALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2020-03-19 | — | — | US | disclosed |
| EP-3617186-A1 | FLUOROALLYLAMINE DERIVATIVE AND USE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2020-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | VAPB, VAPA, SLC28A1 | AOC2 16/4885CPT2 2395/4885CPT1A 333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.